EL-Swefy S, Hassanen SI

Language: Spanish
References: 49
Page: 41-49
PDF size: 264.28 Kb.

Text Extraction

Chronic liver disease is characterized by inflammation and fibrosis. Angiogenesis which leading to new vasculature may have prognostic value in disease progression. This study examined the implication of 5-lipoxygenase pathway and angiogenic factors in hepatic fibrosis progression and whether, the inhibition of arachidonic acid cascade product (cysteinyl leukotrienes) can represent a potential target for therapy. Cholestasis and subsequent fibrosis was induced by common bile duct ligation and resection (BDL) for 5 weeks in rats. After surgery, Cysteinyl leukotrienes antagonist (montelukast) was orally and daily administrated (10 mg/kg) for 34 days. Sham operated and drug control groups received either saline or montelukast immediately after operation. BDL significantly increased liver hydroxyproline (Hp), nuclear factor kappa B (NF-kβ), transforming growth factor beta (TGF-β), tissue inhibitor metalloproteinase (TIMP-1), vascular endothelial growth factor (VEGF), and reduced the level of matrix metalloproteinase 9 (MMP-9). On the other hand, montelukast treatment reversed all these biochemical parameters and ameliorated histopathological changes which previously induced by BDL. Findings of the present study suggest that montelukast treatment may favor collagenolytic activity throughmodulating hepatic expression of TGF-β, NF-kβ, and MMP-9/TIMP-1 ratio. Amelioration of necroinflammatory liver injury and fibrogenesis may support such assumption.

REFERENCES

1. Lee TY, Chang HH, Chen JH, Huseh ML, Kuo JJ. Herb medicine Yin-Chen-Hao-Tang ameliorates hepatic fibrosis in bile duct ligation rats. Journal of Ethnopharmacology 2007; 109: 318-24.

2. Pauli-Magnus C, Meier PJ. Hepatobiliary transporters and drug induced. Hepatology 2006; 44(4): 778-87.

3. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008; 371(9615): 838-51.

4. Steib CJ, Gerbes AL, Bystron M, OP den Winkel M, Hartl J, Rogggel F, Prufer T, Goke B, Bilzer M. Kupffer cell activation in normal and fibrotic livers increases portal pressure via thromboxane A (2). J Hepatol 2007; 47(2): 228-38.

5. Cho MK, Lee GH, Park EY, Kim SG. Hyaluronic acid inhibits adhesion of hepatic stellate cells in spite of its stimulation of DNA synthesis. Tissue Cell 2004; 36(5): 293-305.

6. Yin SS, Li XM, Wang BE, Wang TL, Jia JD, Qian LX. The relationship of serum metalloproteinase with the severity of liver fibrosis and inflammation. Zhonghua Gan Zang Bing Za Zhi 2004; 12(11): 666-68.

7. Guo J, Friedman SL. Hepatic fibrogenesis. Semin Liver Dis 2007; 27(4): 413-26.

8. Guido M, De Franceschi L, Olivari N, Leandro G, Feldr M, Corrocher R, Rugge M, Pasino M, Lanza C, Capelli P, Fattovich G. Effects of interferon plus ribavirin treatment of NF- kappaB, TGF- beta 1, and metalloproteinase activity in chronic hepatitis C. Mod Pathol 2006; 19(8): 1047-54.

9. Kim KR, Moon HE, Kim KW, Hypoxia induced angiogenesis in human hepatocellular carcinoma. J Mol Med 2002; 80(11): 703-14.

10. Skora J, Biegus J, Pupka A, Barc P, Sikora J, Szyber P. Molecular basics of angiogenesis. Postepy Hig Med Dosw 2006; 60: 410-15.

11. Medina J, Sanz-Cameno P, Garcia-Buey L, Martin-Vilchez S, Lopez Cabrera M, Moreno Otero R. Evidence of angiogenesis in primary biliary cirrhosis: an immunohistochemical descriptive study. J Hepatol 2005; 42(1): 124-31.

12. Titos E, Claria J, Bataller R, Bosch- Marce M, Gines P, Jimenez W, Arroyo V, Rivera F, Rodes J. Hepatocyte derived cysteinyl leukotrienes modulate vascular tone in experimental cirrhosis. Gastroenterology 2000; 119(3): 794-805.

13. Sala A, Folco G. Nutrophils, Endothelial cells, and cysteinyl leukotrienes: a new approach to neutrophil dependent inflammation? Biochem Biophys Res Commun 2001; 25, 283(5): 1003-6.

14. Titos E, Claria J, Planaguma A, Lopez Parra M, Villamor N, Parrizas M, Carrio A, Miquel R, Jimenez W, Arroyo V, Rivera F, Rodes J. Inhibition of 5-lipoxygenase induces cell growth arrest and apoptosis in rat kupffer cells: implications for liver fibrosis. FASEB 2003; 17(12): 1745-47.

15. Titos E, Claria J, Planaguma A, Lopez Parra M, Gonzalez Periz A, Gaya J, Miquel R, Arroyo V, Rodes J. Inhibition of 5-lipoxygenase activating protein abrogates experimental liver injury: role of kupffer cells. J Leukoc Biol 2005; 78(4): 871-8.

16. Yang YY, Lin HC, Huang YT, Lee TY, Lee WC, Hou MC, Lee FY, Chang FY, Lee SD. Adaptive vasodilatory response after octreotide treatment. American Journal of Physiology 2001; 281: G117-G123.

17. Sener G, Sakarcan A, Sehirli O, Demiralp EE, Sener E, Ercan F, Gedik N, Yegen BC. Chronic renal failure induced multiple organ injury in rats is alleviated by the selective CysLT-1 receptor antagonist montelukast. Prostaglandins & Other Lipid-Mediators 2007; 83: 257-67.

18. Yang Q, Xie RJ, Luo XH, Han B, Yang T, Fang L. Expression of PKC in rat hepatic fibrosis and the effect of Dan-shao-hua-xian Capsule on its expression pattern. Zhonghua Gan Zang Bing Za Zhi 2005; 13: 707-8.

19. Reitman S, Frankel SA, Colorimetric methods for determination of serum oxaloacetic and glutamic pyruvic transaminases. Am J Clin Pathol 1957; 28: 56-63.

20. Bergmeyer HU, Grabl M, Walter HE, Enzymes. In: Bergmeyer J, Grabl M, Editors. Methods of enzymatic analysis. Weinheim: Verlag Chemic 1983; p. 269- 70.

21. Winsten S, Cehelyk BA, rapid micro diazo technique for measuring total bilirubin. Clin Chim Acta 1969; 25: 441-6.

22. Buge JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978; 52: 302-10.

23. Javelaud D, Mauviel A. Mammalian transforming growth factor betas: S-mad signaling and physio-pathological roles. Int J Biochem Cell Biol 2004; 36: 1161-65.

24. Fujita M, Shannan JM, Morikawa O, Gauldie J, Hara N, Masan RJ, Over expression of tumor necrosis factor b diminishes pulmonary fibrosis induced by blemomycin or transforming growth factor b. American Journal of Respiratory Cell and Molecular Biology 2003; 29: 1-7.

25. Chomkczynski P, Sacchi N. Single step method for RNA isolation by the acid guanidinum thiocyanate phenol chloroform methods. Analytical Biochemistry 1987; 162: 156-160.

26. He-lin D, Ying G, Ming-ton XU, Hai-yan LI, Zu-zhi FU. Effect of angiotensin II receptor blocker on glucose induced mRNA expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rat mesangial cells. Chinese Medical Journal 2007; 21: 18886-89.

27. Drury RA, Wallington EA. Histological techniques. 5th edn, Oxford University press, Oxford 1980: 27-29.

28. Bancroft GD, Stevens A, Turner DR. Theory and practice of technique. 4th edition, Churchill Livingston, New York 1996.

29. Senedecor GW, Cochran WG. Statistical methods 7th ed Iowa Uni. Press. Ames. Iowa USA 1981; 175-191.

30. Park PH, Nan J, Park EJ, Kang HC, Kim JY, Ko G, Sohn DH. Effect of tetrandrine on experimental hepatic fibrosis induced by bile duct ligation and scission in rats. Pharmacology & Toxicology 2000; 87: 261-68.

31. Nishimura D, Imoto M, Satake T et al. Mechanism of liver mitochondrial dysfunction associated with bile duct obstruction. Arzeim Forsch Drug Res 1985; 35: 1427-30.

32. Zhong Z, Froth M, Lehnert M, Schoonhoven R, Yang L, Ling H, Lemasters JJ, Thurman LG. Polyphenols from camcllia sinenesis attenuate experimental cholestasis induced liver fibrosis in rats. Am J Physiol Gastrointest Liver Physiol 2003; 285: G1004-13.

33. Myoshi H, Rust C, Roberts PJ, Burgart LJ, Gores GJ. Hepatocyte apoptosis after bile duct ligation in the mouse involves fas. Gastroenterology 1999; 117: 669-77.

34. Sokol RJ, Devereaux MW, Khandwata R. Effect of oxypurinol a xanthine oxidase inhibitor, on hepatic injury in the bile duct ligated rat. Pediatr Res 1998; 44: 397-401.

35. Hisamori S, Tabata C, Kadokawa Y, Okoshi K, Tabata R, Mori A, Nagayama S, Watanabe G, Kubo H, Sakai Y. All-trans retinoic acid ameliorates carbon tetrachloride induced liver fibrosis in mice through modulating cytokine production. Liver Int 2008 (Epbu ahead of print).

36. Brasier AR, The NF-kappa b regulatory network. Cardlovasc toxicol 2006; 6: 111-30.

37. Anan A, Baskin Bey ES, Bronk SF, Werneburg NW, Shah VH, Gores GJ. Proteasome inhibition induces hepatic stellate cell apoptosis. Hepatology 2006; 43: 335-344.

38. De Minicis S, Seki E, Uchinami H, Kluwe J, Zhang Y, Brenner DA, Schwabe RF. Gene expression profiles during hepatic stellate cell activation in culture and in vivo. Gastroenterology 2007; 132(5): 1937-46.

39. Morlion BJ, Torwesten E, Kuhn KS, Puchstein CP. First Cysteinyl leukotriene generation as a biomarker for survival hr the critically ill. Crit Care Med 2000; 28: 3655-58.

40. Zhao ZJ, Liu XM, Zhou GP. Changes of matrix metalloproteinase 2, 9 and tissue inhibitor of metalloproteinase 1, 2, 3 expression level in aged rat lung. Beijing Da Xue Xue Bao 2008; 40(1): 101-4.

41. Ueno T, Nakamura T, Torimura T, Sata M. Angiogenic cell therapy for hepatic fibrosis. Med Mol Morphol 2006; 39(1): 16-21.

42. Medina J, Sanz-Cameno P, García-Buey L, Martín-Vílchez S, López-Cabrera M, Moreno-Otero R. Evidence of angiogenesis in primary biliary cirrhosis: an immunohistochemical descriptive study. J Hepatol 2005; 42: 124-31.

43. Takeshita A, Shibayama Y. Role of mast cells in hepatic remodeling during cholestasis and its resolution: relevance to regulation of apoptosis. Experimental Toxicological and Pathology 2005; 56: b273-80.

44. Rossi A, Acquaviva AM, Iuliano F, Di Paola R, Cuzzocrea S, Sautebin L. Up-regulation of prostaglandin biosynthesis by leukotrience C4 in elicited mice peritoneal macrophages activated with lipopolysaccharide/interferon (gamma). J Leukoc Biol 2005; 78(4): 985-91.

45. Sener S, Kabasakal L, Cetinel S, Contuk G, Gedik N, Yegen BC. Lukotriene receptor blocker montelukast protects against burn induced oxidative injury of the skin and remote organs. Burns 2005; 31: 587-96.

46. Kanazawa H, Nomura S, Asai K. Roles of angiopoietin-1 and angiopoietin-2 on airway microvascular permeability in asthmatic patients. Chest 2007; 131(4): 1035-41.

47. Atakan A, Arikan H, Macunluoglu B, Tuglular S, Ulfer G, Cakalagaoglu F, Ozener C, Akoglu E. Renal protective effects of leukotriene receptor blockers in an experimental model of cyclosporine nephrotoxicity. Transplant Proc 2008; 40(1): 279-84.

48. Hus YC, Chiu YT, Lee CY, Wu CF, Huang YT. Anti fibrotic effects of tetrandrine on bile duct ligated rats. Can J Physiol Pharmacol 2006; 84(10): 967-76.

49. Wang HY, Cheng ML. Effects of Dan Shao-Hua-xian on expression of PPAR- gamma and NF-Kappa B in rat liver fibrosis. Hepatobiliary Pancreat Dis Int 2008; 7(2): 179-84.